Barclays raised the firm’s price target on Strategy (MSTR) to $475 from $421 and keeps an Overweight rating on the shares.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MSTR:
- Insider Moves: Procter & Gamble, Strategy, Merck, Bristol-Myers, AGNC
- MicroStrategy’s Earnings Call: Bitcoin Strategy Shines
- Crypto Currents: Riot Platforms, Strategy report Q1 earnings
- 3 Best Stocks to Buy Now, 5/2/2025, According to Top Analysts
- Strategy price target raised to $630 from $560 at Keefe Bruyette